Skip to main content
. 2001 Oct 23;2001(4):CD003159. doi: 10.1002/14651858.CD003159

Roelandts 1994.

Methods multinational, multicentre, double blind, randomized, placebo controlled, parallel groups
Participants Senile dementia mild to moderate; 82 patients received nicergoline, 80 placebo; age > 55.
Interventions Nicergoline or Placebo 30mg. twice a day (os) for 6 months
Outcomes SCAG, GRS, MACC for efficacy; adverse events for safety
Notes